ALISO VIEJO, Calif., April 3, 2008 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has launched EnCor(r), its flagship vacuum-assisted breast biopsy product, and its line of breast biopsy tissue markers in additional countries outside the U.S. SenoRx products will now also be marketed through distributors in Germany, France, Italy, Russia and the Nordic countries. SenoRx had previously announced in October 2007 that it was partnering with local distributors with breast imaging and/or interventional radiology franchises in Austria, Belgium, United Kingdom, Hong Kong, Ireland, Luxembourg, The Netherlands, Singapore, Switzerland and Taiwan. EnCor and SenoRx breast tissue markers have previously received the necessary regulatory clearances in the European Economic Community and in these and several other countries in Asia.
"Following successful test marketing of EnCor in several countries outside the United States early last year," said Lloyd Malchow, SenoRx President and Chief Executive Officer, "we began establishing agreements with selected distributors to sell EnCor and our line of tissue markers. We indicated at that time that we intended further expansion of our marketing efforts in additional countries beginning in 2008.
"We have been pleased with the progress achieved in our initial launch in the first ten countries outside of the U.S. and have been particularly impressed with the traction we have gained in the U.K., Belgium and The Netherlands. Our initial positive experiences in these markets have provided us with an adequate basis to move forward with our planned expansion to launch in additional countries," Malchow added.
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its flagship EnCor(r) system and Contura(tm) MLB. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605